Department of Surgery, Center for Digestive Diseases, International University of Health and Welfare, Mita Hospital, Japan.
J Gastroenterol Hepatol. 2012 Apr;27 Suppl 3:29-33. doi: 10.1111/j.1440-1746.2012.07067.x.
We seek for the accurate and simple method for detecting sentinel nodes of gastric cancer which can be popularized in community hospitals. The indocyanine green (ICG) fluorescence-guided method is reported to be sensitive. However, the ordinal fluorescence cameras have gray scale imaging and require a dark room. We have developed a new device, Hyper Eye Medical System (HEMS) which can simultaneously detect color and near-infrared rays and can be used under room light. This study was planned to examine whether submucosal injection of 0.5 mL × 4 of 50 µg/mL ICG on the day before operation is the adequate administration for detecting sentinel nodes using HEMS in the gastric cancer surgery.
The patients underwent gastrectomy for clinical T1a (mucosa)-T2 (muscularis propria) and clinical N0 were enrolled in the present study. As a preliminary trial, one case each of the ICG 25 and 100 µg/mL, injected on the day before operation and intraoperative injection, was examined. Then, 10 cases injected 50 µg/mL ICG on the day before operation were examined.
The ICG fluorescence of the patient injected 100 µg/mL was too intense and that of the patient injected 25 µg/mL was too faint. Sentinel lymph nodes were detected in all of 10 cases injected 50 µg/mL, the day before operation and number of sentinel lymph nodes per patient was 3.6 ± 2.1. Metastasis was observed in one case. All of ICG fluorescence-positive sentinel nodes were positive for the metastasis. In the patient who underwent intraoperative injection, sentinel lymphatic basins could be identified.
The present study shows that HEMS-guided abdominal surgery is feasible under room light. Submucosal injection of 0.5 mL × 4 of 50 µg/mL ICG on the day before operation is the adequate administration for detecting sentinel nodes using HEMS in the gastric cancer surgery.
我们旨在寻找一种准确且简便的方法来检测胃癌的前哨淋巴结,使其能够在社区医院得到推广。吲哚菁绿(ICG)荧光引导法被认为具有较高的敏感性。然而,这种方法需要使用灰度成像的序贯荧光摄像机,并且需要在暗室中进行。我们开发了一种新的设备,即 Hyper Eye 医疗系统(HEMS),它可以同时检测颜色和近红外光,并且可以在室内光照下使用。本研究旨在检验在术前一天行黏膜下注射 0.5 mL×4 支、50 µg/mL 的 ICG 是否足以通过 HEMS 检测胃癌手术中的前哨淋巴结。
本研究纳入了接受胃癌根治术的临床 T1a(黏膜)-T2(固有肌层)和临床 N0 患者。作为初步试验,我们分别对术前一天和术中注射 ICG 浓度为 25 µg/mL 和 100 µg/mL 的各 1 例患者进行了检验。然后,我们对术前一天注射 50 µg/mL ICG 的 10 例患者进行了检验。
注射 100 µg/mL ICG 的患者荧光过强,而注射 25 µg/mL ICG 的患者荧光过弱。在术前一天注射 50 µg/mL ICG 的 10 例患者中均检测到了前哨淋巴结,每位患者的前哨淋巴结数量为 3.6±2.1。1 例患者发生了转移。所有 ICG 荧光阳性的前哨淋巴结均发生了转移。在术中注射的患者中,也可以识别前哨淋巴结区域。
本研究表明,HEMS 引导的腹部手术可以在室内光照下进行。在胃癌手术中,术前一天行黏膜下注射 0.5 mL×4 支、50 µg/mL 的 ICG 是通过 HEMS 检测前哨淋巴结的有效方法。